IFN-y and IL-17 signaling are crucial canonical pathways involved in MDSC immunomodulation: IFN-y triggers the immunosuppressive properties of MDSCs, whereas IL-17 induces MDSC tumor invasion [98]. This evidence concerns the gene IL17A and neoplasm.